President Donald Trump is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut the costs associated with prescription drugs.

GLP-1 receptor agonists like semaglutide are being used off-label by healthy people hoping to slow ageing, despite limited evidence and unknown long-term risks.

Amgen Inc. and GSK plc are reportedly set to announce their partnership with TrumpRx.gov. This collaboration is set to offer ...

Ayurveda is a comprehensive therapy as it aims at reducing inflammation, enhancing digestion, stabilizing the equilibrium with herbs, diet, detoxification and lifestyle changes to maintain the immune ...

Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and potential side effects.

New guidelines recommend considering cholesterol-lowering statins in the 30s, screening all adults for hidden risk factors ...

Immutep ( (IMMP)) has issued an announcement. On March 19, 2026, Immutep reported positive progress from its first-in-human Phase I trial of IMP761, a first-in-class LAG-3 agonist antibody for ...

The new guidelines aim to give doctors and their patients an individualized and clear path to follow. Heart disease remains the leading cause of death worldwide, according to the ...

Psychologist, author and surrogacy advocate Kim Bergman joins WIRED to answer the internet’s burning questions about being a ...

Detailed price information for Acumen Pharmaceuticals Inc (ABOS-Q) from The Globe and Mail including charting and trades.

Debates around the boundaries of medicine, law and personal autonomy took centre stage, and after a significant ruling by the ...

Following through with its sizable investment commitment in China, AstraZeneca on Thursday unveiled plans to build a commercial cell therapy manufacturing base and an innovation center dedicated to | ...